<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0163945.ref028">
 <label>28</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Poordad</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Hezode</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Trinh</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Kowdley</surname>
   <given-names>KV</given-names>
  </name>, 
  <name>
   <surname>Zeuzem</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Agarwal</surname>
   <given-names>K</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2014</year>;
  <volume>370</volume>(
  <issue>21</issue>):
  <fpage>1973</fpage>â€“
  <lpage>82</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1402869</pub-id> .
  <?supplied-pmid 24725237?>
  <pub-id pub-id-type="pmid">24725237</pub-id>
 </mixed-citation>
</ref>
